The eyes of the people in the audience at the opening general session of the the 7th Annual Pharmaceutical Meeting Management Forum got bigger and bigger as Thomas Forrester, who at the time was U.S. Corporate Compliance Officer, sanofi-aventis, detailed the consequences of not complying with today’s regulations—from enormous fines to criminal penalties for company execs. As more than one person remarked afterward, “Now that was scary!” Fortunately, Forrester, ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to The Risks and Rewards of Pharmaceutical Meetings, you'll get exclusive access to a large archive of premium content.

Already registered? here.